Kuwait vs Sri Lanka: Access to anti-retroviral drugs, male
Kuwait
71.0%
in 2024
Sri Lanka
71.0%
in 2024
Kuwait rank
69th
Sri Lanka rank
69th
Access to anti-retroviral drugs, male over time
- Kuwait
- Sri Lanka
How they compare
Kuwait currently reports 71.0% against 71.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Kuwait ahead.
Kuwait ranks 69th and Sri Lanka ranks 69th of 141 countries.
Across the 3 decades both report, Kuwait averaged higher in 2 and Sri Lanka in 1.
Head to head by decade
| Decade | Kuwait | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.4% | 1.2% | 37.2% | Kuwait |
| 2010s | 35.4% | 19.6% | 15.8% | Kuwait |
| 2020s | 55.8% | 56.0% | 0.2% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Kuwait or Sri Lanka?
- Kuwait, at 71.0% against 71.0% in Sri Lanka as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Kuwait and Sri Lanka?
- 0.0%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Sri Lanka?
- 25 years are reported by both, from 2000 to 2024.
- How do Kuwait and Sri Lanka rank globally for access to anti-retroviral drugs, male?
- Kuwait ranks 69th and Sri Lanka ranks 69th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.